We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Top Sells

Rank Stock Value
1
VER
VEREIT, Inc.
VER
+$434M
2
CONE
CyrusOne Inc Common Stock
CONE
+$386M
3
WY icon
Weyerhaeuser
WY
+$118M
4
HR icon
Healthcare Realty
HR
+$68.6M
5
VTR icon
Ventas
VTR
+$64.7M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CM icon
1126
Canadian Imperial Bank of Commerce
CM
$107B
$9K ﹤0.01%
150
-120
-44% -$6.98K
FOLD
1127
DELISTED
Amicus Therapeutics
FOLD
$9K ﹤0.01%
813
-100
-11% -$1.11K
INSM icon
1128
Insmed
INSM
$22.7B
$9K ﹤0.01%
345
-50
-13% -$1.43K
IOVA icon
1129
Iovance Biotherapeutics
IOVA
$2.03B
$9K ﹤0.01%
458
-73
-14% -$1.61K
OSCR icon
1130
Oscar Health
OSCR
$9.22B
$9K ﹤0.01%
1,146
-4,358
-79% -$54.7K
SANA icon
1131
Sana Biotechnology
SANA
$854M
$9K ﹤0.01%
+551
New +$10.6K
SWTX
1132
DELISTED
SpringWorks Therapeutics
SWTX
$9K ﹤0.01%
144
-24
-14% -$1.59K
VCYT icon
1133
Veracyte
VCYT
$4.46B
$9K ﹤0.01%
207
-36
-15% -$1.59K
LGND icon
1134
Ligand Pharmaceuticals
LGND
$5.89B
$8K ﹤0.01%
79
-12
-13% -$1.11K
PCRX icon
1135
Pacira BioSciences
PCRX
$1.04B
$8K ﹤0.01%
130
-22
-14% -$1.21K
PRTA icon
1136
Prothena Corp
PRTA
$442M
$8K ﹤0.01%
154
– –
PTCT icon
1137
PTC Therapeutics
PTCT
$6.17B
$8K ﹤0.01%
206
-36
-15% -$1.38K
BBIO icon
1138
BridgeBio Pharma
BBIO
$16.5B
$7K ﹤0.01%
429
-84
-16% -$3.55K
BCRX icon
1139
BioCryst Pharmaceuticals
BCRX
$2.43B
$7K ﹤0.01%
525
-88
-14% -$1.17K
HRMY icon
1140
Harmony Biosciences
HRMY
$2.07B
$7K ﹤0.01%
+171
New +$6.82K
NBP
1141
NovaBridge Biosciences American Depositary Shares
NBP
$193M
$7K ﹤0.01%
144
– –
MMYT icon
1142
PUT
MakeMyTrip
MMYT
$5.25B
$7K ﹤0.01%
+32
New +$952
MYGN icon
1143
Myriad Genetics
MYGN
$481M
$7K ﹤0.01%
267
– –
NKTR icon
1144
Nektar Therapeutics
NKTR
$2.32B
$7K ﹤0.01%
36
-6
-14% -$1.3K
SAGE
1145
DELISTED
Sage Therapeutics
SAGE
$7K ﹤0.01%
172
-29
-14% -$1.21K
XNCR icon
1146
Xencor
XNCR
$1.45B
$7K ﹤0.01%
171
-29
-15% -$1.1K
NSTG
1147
DELISTED
NanoString Technologies, Inc.
NSTG
$7K ﹤0.01%
156
– –
CCXI
1148
DELISTED
ChemoCentryx, Inc.
CCXI
$7K ﹤0.01%
204
-35
-15% -$1.23K
TPTX
1149
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$7K ﹤0.01%
144
-25
-15% -$1.12K
ALEC icon
1150
Alector
ALEC
$168M
$6K ﹤0.01%
277
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.